Haleon PLC Sponsored ADR (NYSE:HLN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Haleon PLC Sponsored ADR (NYSE:HLN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, two have given a buy rating and two have given a strong buy rating to the company.

HLN has been the subject of several recent research reports. Morgan Stanley reissued an “overweight” rating on shares of Haleon in a research note on Thursday, August 6th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a research report on Wednesday. Jefferies Financial Group reiterated a “buy” rating on shares of Haleon in a report on Monday, August 24th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Finally, Rothschild & Co Redburn lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th.

Get Haleon alerts:

Get Our Latest Stock Report on HLN

Institutional Trading of Haleon

Institutional investors have recently added to or reduced their stakes in the stock. IHT Wealth Management LLC lifted its holdings in Haleon by 6.9% during the 4th quarter. IHT Wealth Management LLC now owns 16,205 shares of the company’s stock worth $164,000 after buying an additional 1,049 shares in the last quarter. Parkside Financial Bank & Trust raised its position in Haleon by 20.4% in the 2nd quarter. Parkside Financial Bank & Trust now owns 6,233 shares of the company’s stock valued at $58,000 after purchasing an additional 1,055 shares in the last quarter. National Bank of Canada FI raised its position in Haleon by 6.7% in the 3rd quarter. National Bank of Canada FI now owns 17,385 shares of the company’s stock valued at $156,000 after purchasing an additional 1,099 shares in the last quarter. Oppenheimer & Co. Inc. grew its position in shares of Haleon by 4.7% during the fourth quarter. Oppenheimer & Co. Inc. now owns 24,744 shares of the company’s stock worth $250,000 after buying an additional 1,100 shares in the last quarter. Finally, Cary Street Partners Financial LLC lifted its stake in Haleon by 20.1% in the second quarter. Cary Street Partners Financial LLC now owns 6,646 shares of the company’s stock worth $69,000 after acquiring an additional 1,113 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Trading Down 0.2%

HLN stock opened at $9.23 on Thursday. Haleon has a 52-week low of $8.65 and a 52-week high of $11.28. The company has a quick ratio of 0.52, a current ratio of 0.69 and a debt-to-equity ratio of 0.38. The firm has a market cap of $40.62 billion, a P/E ratio of 23.68, a PEG ratio of 2.06 and a beta of 0.12. The company’s 50-day simple moving average is $9.88 and its 200-day simple moving average is $9.71.

Haleon Cuts Dividend

The company also recently declared a dividend, which will be paid on Thursday, September 17th. Stockholders of record on Friday, August 14th will be given a dividend of $0.0642 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a dividend yield of 132.0%. Haleon’s payout ratio is presently 30.77%.

Haleon Company Profile

(Get Free Report)

Haleon plc (NYSE: HLN) is a global consumer healthcare company that develops, manufactures and markets products for everyday health and wellness needs. Its portfolio spans oral health, pain relief, respiratory health, vitamins and supplements, digestive health, and therapeutic skin care.

Haleon’s well-known brands include Sensodyne, Polident, parodontax, Voltaren, Panadol, Advil, Centrum, Emergen-C, Theraflu, Otrivin, Calpol, ChapStick and Excedrin. The company sells its products through pharmacies, supermarkets, mass retailers, e-commerce platforms and other healthcare channels.

Haleon was formed through the demerger of GSK’s consumer healthcare business and became an independent company in 2022.

Read More

• Five stocks we like better than Haleon
• Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
• GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
• Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
• Sovereign AI: Palantir and Nebius Cut the Cloud Cord

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.